Campylobacter jejuni targets immunoglobulin-like receptor LMIR5

Molecular Immunology

Volumn 63, Issue 2, 2015, Pages 574-578

  Phongsisay, Vongsavanh ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Campylobacter jejuni; Immune responses; LMIR5 CD300b; Receptor

Indexed keywords

GLYCOCONJUGATE; IMMUNOGLOBULIN RECEPTOR; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; LECTIN; PROTEIN LMIR5; PROTEIN LMIR8; PROTEIN SIGNR1; PROTEIN SIGNR3; PROTEIN TREM2; PROTEIN TREM3; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; CD300LB PROTEIN, HUMAN; MEMBRANE PROTEIN; RNA; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TYROBP PROTEIN, HUMAN;

ARTICLE; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; IMMUNOPATHOLOGY; INNATE IMMUNITY; MOLECULAR WEIGHT; NONHUMAN; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR POTENTIAL; SIGNAL TRANSDUCTION; HUMAN; METABOLISM;

CAMPYLOBACTER JEJUNI;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CAMPYLOBACTER JEJUNI; GLYCOCONJUGATES; HUMANS; MEMBRANE PROTEINS; MOLECULAR WEIGHT; NFATC TRANSCRIPTION FACTORS; RECEPTORS, IMMUNOLOGIC; RNA;

EID: 84912027892     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.07.024     Document Type: Article

References (19)

1. Avril T., Wagner E.R., Willison H.J., Crocker P.R. Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infect. Immun. 2006, 74:4133-4141.
2. Bakker A.B., Hoek R.M., Cerwenka A., Blom B., Lucian L., McNeil T., Murray R., Phillips L.H., Sedqwick J.D., Lanier L.L. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 2000, 13:345-353.
3. Colonna M. TREMs in the immune system and beyond. Nat. Rev. Immunol. 2003, 3:445-453.
4. García-Vallejo J.J., van Kooyk Y. Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis. Immunol. Rev. 2009, 230:22-37.
5. Gasiorowski R.E., Ju X., Hart D.N., Clark G.J. CD300 molecule regulation of human dendritic cell functions. Immunol. Lett. 2013, 149:93-100.
6. Heikema A.P., Bergman M.P., Richards H., Crocker P.R., Gilbert M., Samsom J.N., van Wamel W.J., Endtz H.P., van Belkum A. Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides. Infect. Immun. 2010, 78:3237-3246.
7. Hoving J.C., Wilson G.J., Brown G.D. Signalling C-type lectin receptors, microbial recognition and immunity. Cell. Microbiol. 2014, 16:185-194.
8. Karlyshev A.V., Linton D., Gregson N.A., Lastovica A.J., Wren B.W. Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity. Mol. Microbiol. 2000, 35:529-541.
9. Martinez-Barriocanal A., Sayos J. Molecular and functional characterization of CD300b, a new activating immunoglobulin receptor able to transduce signals through two different pathways. J. Immunol. 2006, 177:2819-2830.
10. Nothaft H., Szymanski C.M. Protein glycosylation in bacteria: sweeter than ever. Nat. Rev. Microbiol. 2010, 8:765-778.
11. Phongsisay V., Iizasa E., Hara H., Yamasaki S. LMIR5 extracellular domain activates myeloid cells through Toll-like receptor 4. Mol. Immunol. 2014, 62:169-177.
12. Phongsisay V., Perera V.N., Fry B.N. Exchange of lipooligosaccharide synthesis genes creates potential Guillain-Barré syndrome-inducible strains of Campylobacter jejuni. Infect. Immun. 2006, 74:1368-1372.
13. Stephenson H.N., John C.M., Naz N., Gundogdu O., Dorrell N., Wren B.W., Jarvis G.A., Bajaj-Elliott M. Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide/ester linkage modifications fine-tune human Toll-like receptor 4 activation. J. Biol. Chem. 2013, 288:19661-19672.
14. van Sorge N.M., Bleumink N.M., van Vliet S.J., Saeland E., van der Pol W.L., van Kooyk Y., van Putten J.P. N-glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL. Cell. Microbiol. 2009, 11:1768-1781.
15. Yamanishi Y., Kitaura J., Izawa K., Kaitani A., Komeno Y., Nakamura M., Yamazaki S., Enomoto Y., Oki T., Akiba H., Abe T., Komori T., Morikawa Y., Kiyonari H., Takai T., Okumura K., Kitamura T. TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. J. Exp. Med. 2010, 207:1501-1511.
16. Yamanishi Y., Kitaura J., Izawa K., Matsuoka T., Oki T., Lu Y., Shibata F., Yamazaki S., Kumagai H., Nakajima H., Maeda-Yamamoto M., Tybulewicz V.L., Takai T., Kitamura T. Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells. Blood 2008, 111:688-698.
17. Yamanishi Y., Takahashi M., Izawa K., Isobe M., Ito S., Tsuchiya A., Maehara A., Kaitani A., Uchida T., Togami K., Enomoto Y., Nakahara F., Oki T., Kajikawa M., Kurihara H., Kitamura T., Kitaura J. A soluble form of LMIR5/CD300b amplifies lipopolysaccharide-induced lethal inflammation in sepsis. J. Immunol. 2012, 189:1773-1779.
18. Yamasaki S., Ishikawa E., Sakuma M., Hara H., Ogata K., Saito T. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat. Immunol. 2008, 9:1179-1188.
19. Yuki N., Susuki K., Koga M., Nishimoto Y., Odaka M., Hirata K., Taguchi K., Miyatake T., Furukawa K., Kobata T., Yamada M. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11404-11409.